Guru Ownership Trend
Guru Analysis for Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $79.1 M.
Top institutional holders include Stanley Druckenmiller and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $24.5 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 103.9%. Conversely, Joel Greenblatt reduced exposure by 88.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Caris Life Sciences, Inc. (CAI)
Major holders include Stanley Druckenmiller ($33.76 M), Renaissance Technologies (RenTech) ($10.12 M), Paul Tudor Jones ($1.79 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.78 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $24.5 M, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited CAI. The total reported sell value was $28.28 M.
Yes, 1 managers opened new positions in CAI, and 2 increased their existing holdings. The total reported buy value was $3.78 M.